| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381111A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | CA2376180A1 Oral liquid compositions |
| 02/28/2001 | EP1078634A1 Medicament for inhibiting NF-kB |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078005A1 Methods for amyloid removal using anti-amyloid antibodies |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077936A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077702A1 Peripheral benzodiazepine receptor ligands |
| 02/28/2001 | EP1077694A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1285214A Traditional Chinese medicine for treating headache |
| 02/28/2001 | CN1285202A Huoqingzhengyang medicine |
| 02/28/2001 | CN1285201A Medicine for warming kidney and treating wind-dampness syndrome and preparation process thereof |
| 02/28/2001 | CN1285199A Shexiangzhuifeng plaster |
| 02/28/2001 | CN1285196A Shubi plaster for treating arthralgia due to wind-cold-dampness |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | USRE37078 Antiinflammatory agents, antiarthritic agents |
| 02/27/2001 | US6194585 Process for preparing 5-lipoxygenase inhibitors |
| 02/27/2001 | US6194565 Antiinflammatory agent |
| 02/27/2001 | US6194469 Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| 02/27/2001 | US6194462 Pharmaceutical preparation containing nimesulide for oral administration |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194456 Method for inhibiting inflammation |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof |
| 02/27/2001 | US6194449 Allosteric adenosine receptor modulators |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194431 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid |
| 02/27/2001 | US6194392 Administering to a patient suffering from swelling associated with brain tumours involving tissue of the group consisting of underperfused tissue and pathological tissue an antiswelling agent and a hyaluronic acid to aid penetration |
| 02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
| 02/27/2001 | US6194020 Conserving procyanidins(catechins); candy |
| 02/27/2001 | US6194003 Process for making flurbiprofen lozenges |
| 02/27/2001 | US6193996 Device for the transdermal delivery of diclofenac |
| 02/27/2001 | US6193979 Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands |
| 02/27/2001 | US6193977 For treating pain and inflammation as in chronic gastritis, arthralgia, benign prostate hyperplasia, chronic and recurrent cystitis, cervical disc, degenerative joint arthritis, rheumatoid arthritis, tennis elbow, osteoportotic pain |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193957 For prophylaxis and therapy of airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, inflammatory bowel disease or rheumatoid arthritis |
| 02/27/2001 | CA2191230C 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease |
| 02/27/2001 | CA2189526C Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012633A1 Water soluble sdz-rad esters |
| 02/22/2001 | WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/22/2001 | WO2001012621A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 02/22/2001 | WO2001012606A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012592A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | WO2001012588A1 Salicylamide derivatives |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012264A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 02/22/2001 | WO2001012229A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | WO2001012222A1 Immunological tolerance-induction agent |
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2001012180A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 02/22/2001 | WO2001012175A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 02/22/2001 | WO2001012165A1 Rolled external-use patch |
| 02/22/2001 | WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | WO2001011967A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |